Multicenter clinical study of neonatal lysosomal disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047824

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal lysosomal disease

Interventions

Case group:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Postnatal age <= 28 days; 2. Sign informed consent; 3. Clinical diagnosis and treatment of suspected genetic metabolic diseases.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Clinical outcome;Genetic metabolic screening;	—

Countries

China

Contacts

Public ContactFeng Zhichun

The Seventh Medical Center of PLA General Hospital

Zhjfengzc@126.com+86 10 66721786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026